Request Deal Involvement

Carlyle-backed SeQuent Scientific to merge Viyash Lifesciences in an INR80bn deal.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

PricewaterhouseCoopers

accounting advisors

PricewaterhouseCoopers

Ernst & Young

financial advisors

Ernst & Young

Trilegal

legal advisors

Trilegal

ICICI Bank

financial advisors

ICICI Bank

KPMG

accounting advisors

KPMG

JM Financial

financial advisors

JM Financial

KPMG

financial advisors

KPMG

AZB & Partners

legal advisors

AZB & Partners

Bain & Co

commercial advisors

Bain & Co

or

Principals

VIYASH LIFE SCIENCES

target

VIYASH LIFE SCIENCES

SEQUENT SCIENTIFIC LIMITED

bidder

SEQUENT SCIENTIFIC LIMITED

THE CARLYLE GROUP

bidder

THE CARLYLE GROUP

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Carlyle-backed SeQuent Scientific to merge Viyash Lifesciences in an INR80bn deal.